Cleared Special

K123379 - ABBOTT ARCHITECT FREE T4

K123379 is an FDA 510(k) clearance for ABBOTT ARCHITECT FREE T4, manufactured by Abbott Laboratories. The device is a Class 2 Chemistry device with product code CEC cleared through the Special 510(k) pathway after a 26-day FDA review.

K123379 · Abbott Laboratories · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2012
Decision
26d
Days
Class 2
Risk

K123379 is an FDA 510(k) clearance for the ABBOTT ARCHITECT FREE T4. Classified as Radioimmunoassay, Free Thyroxine (product code CEC), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on November 27, 2012 after a review of 26 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1695 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K123379

510(k) Number K123379 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 01, 2012
Decision Date November 27, 2012
Days to Decision 26 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 88d · This submission: 26d
Pathway characteristics
Modification to existing cleared device.

CEC Device Classification - Class 2, Special Controls

Product Code CEC Radioimmunoassay, Free Thyroxine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1695
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CEC Radioimmunoassay, Free Thyroxine

All 66
Devices cleared under the same product code (CEC) and FDA review panel - the closest regulatory comparables to K123379.
ELECSYS FT4 II ASSAY, ELECSYS FT4 II CALSET
K131244 · Roche Diagnostics · Jan 2014
ADVIA CENTAUR FT4, ADVIA CENTAUR T4
K132249 · Siemens Healthcare Diagnostics, Inc. · Sep 2013
LIAISON FT4 LIAISON CONTROL THYROID 1 LIAISON CONTROL THYROID 2 LIAISON CONTROL THYROID 3
K121951 · DiaSorin, Inc. · Apr 2013
IMMULITE 2000 FREE T4
K083373 · Siemens Healthcare Diagnostics, Inc. · Feb 2009
ACS 180 AND ADVIA CENTAUR FT4 IMMUNOASSAYS
K080167 · Siemens Healthcare Diagnostics · Aug 2008
DIMENSION EXL WITH LM CLINICAL CHEMISTRY SYSTEM, DIMENSION FT4L FLEX REAGENT CARTRIDGE, AND LOCI THYROID CALIBRATOR, MOD
K073604 · Dade Behring, Inc. · Mar 2008